Diagnostic Kit for Neutrophil gelatinase-associated lipocalin (NGAL)

Primary DI

06974521003304

Basic UDI-DI Code

B-06974521003304

Reference

SUPF069025

Device Types

Single use

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Shenzhen Superbio Technology Co.,Ltd.

This kit is suitable for the in vitro quantitative detection of neutrophil gelatinase-associated lipocalin (NGAL) in human serum, whole blood, plasma and urine samples, and is mainly used clinically to assist in the diagnosis of renal impairment. Neutrophil gelatinase-associated lipocalin (NGAL), also known as human lipocalin 2 (Ln2) or siderocalin, is a new member of the human lipocalin family. In recent years, NGAL has attracted much attention as a new marker of kidney injury. The serum and urine levels of NGAL in early acute kidney injury, chronic kidney disease, cardiorenal syndrome and other diseases will significantly increase, and its level monitoring has good diagnostic value for the severity of the disease, the efficacy and prognosis.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).